Notice of Extension for PAR-25-157 “Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)”
Notice Number:
NOT-TR-25-009
Key Dates
Release Date:
June 5, 2025
Related Announcements
- December 10, 2024 - Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed). See NOFO PAR-25-157
Issued by
National Center for Advancing Translational Sciences (NCATS)
Purpose
The purpose of this Notice is to inform applicants that effective immediately the National Center for Advancing Translational Sciences (NCATS) is extending PAR-25-157 “Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)” by one Council round.
The following text in bold and italics has been updated to reflect the extension:
Part 1. Overview Information
Key Dates
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| June 19, 2025 | June 19, 2025 | Not Applicable | October 2025 | January 2026 | April 2026 |
| June 18, 2026 | June 18, 2026 | Not Applicable | October 2026 | January 2027 | April 2027 |
Expiration Date: June 19, 2026
All other aspects of the NOFO remain the same.
Inquiries
Please direct all inquiries to:
Kihwa Kang, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-5634
Email: [email protected]
Department of Health
and Human Services (HHS)
and Human Services (HHS)
